China Orthopedic Procedures Outlook to 2020: Worldwide Industry Share, Investment Trends, Growth, Size, Strategy and Forecast Research Report
Markets Research Reports.biz added deep and professional market research reports on "China Orthopedic Procedures Outlook To 2020" Market Analysis and Overview. Visit: http://www.marketresearchreports.biz/analysis/194695.
(PRWEB) April 17, 2014
New report, "China Orthopedic Procedures Outlook to 2020", provides key procedures data on the China Orthopedic Procedures. The report provides procedure volumes within market categories Hip Replacement Procedures, Knee Replacement Procedures, Shoulder Replacement Procedures, Small Joints Procedures, Arthroscopy Procedures, Cranio Maxillofacial Fixation (CMF) Procedures, Spinal Surgery Procedures, Trauma Fixation Procedures, Orthopedic Prosthetics (Amputation Procedures) and Orthobiologics Procedures (Bone Graft Procedures).
Browse full report with TOC: http://www.marketresearchreports.biz/analysis-details/china-orthopedic-procedures-outlook-to-2020.
The data in the report is derived from dynamic market forecast models. GlobalData uses epidemiology based models to estimate and forecast the procedure volumes. The objective is to provide information that represents the most up-to-date data of the industry possible.
The epidemiology-based forecasting model makes use of epidemiology data gathered from research publications and primary interviews with physicians to establish the target patient population and treatment flow patterns for individual diseases and therapies. Using prevalence and incidence data and diagnosed and treated population, the epidemiology-based forecasting model arrives at the final numbers.
Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the procedure volumes.
Procedure volumes data for Orthopedic market categories Hip Replacement Procedures, Knee Replacement Procedures, Shoulder Replacement Procedures, Small Joints Procedures, Arthroscopy Procedures, Cranio Maxillofacial Fixation (CMF) Procedures, Spinal Surgery Procedures, Trauma Fixation Procedures, Orthopedic Prosthetics (Amputation Procedures) and Orthobiologics Procedures (Bone Graft Procedures).
Projections for each of the market categories. Data is provided from 2005 to 2012 and forecast to 2020.
To download full report with TOC: http://www.marketresearchreports.biz/sample/sample/194695.
Reasons to buy
Develop business and investment strategies by identifying the key market segments expected to register strong growth in the near future.
Develop market-entry and market expansion strategies.
Table of Contents
1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2.1 What Is This Report About?
2.2 Orthopedic Procedures Segmentation
2.3 Definitions of Procedures Covered in the Report
3 Orthopedic Procedures, China
3.1 Orthopedic Procedures, China, 2005-2020
3.2 Orthopedic Procedures Market, China, Category Comparison by Procedures, 2005-2020
3.3 Orthopedic Procedures, China, 2005-2012
3.4 Orthopedic Procedures, China, 2012-2020
4 Arthroscopy Procedures, China
4.2 Arthroscopy Procedures, China, 2012-2020
5 Cranio Maxillofacial Fixation (CMF) Procedures, China
5.1 Cranio Maxillofacial Fixation (CMF) Procedures, China, 2005-2012
5.2 Cranio Maxillofacial Fixation (CMF) Procedures, China, 2012-2020
To inquiry before buying report: http://www.marketresearchreports.biz/analysis/194695.
6 Hip Replacement Procedures, China
6.1 Hip Replacement Procedures, China, 2005-2012
6.2 Hip Replacement Procedures, China, 2012-2020
6.2.1 Primary Hip Replacement Procedures (Cemented and Cementless), China, 2005-2012
6.2.2 Primary Hip Replacement Procedures (Cemented and Cementless), China, 2012-2020
6.2.3 Primary Hip Replacement Procedures (Unilateral and Bilateral), China, 2005-2012
7 Knee Replacement Procedures, China
7.1 Knee Replacement Procedures, China, 2005-2012
7.2 Knee Replacement Procedures, China, 2012-2020
7.2.1 Knee Replacement Procedures (Unilateral and Bilateral), China, 2005-2012
7.2.2 Knee Replacement Procedures (Unilateral and Bilateral), China, 2012-2020
7.2.3 Primary Knee Replacement Procedures (Cemented and Cementless), China, 2005-2012
7.2.4 Primary Knee Replacement Procedures (Cemented and Cementless), China, 2012-2020
8 Orthobiologics Procedures, China
8.1 Orthobiologics Procedures, China, 2005-2012
8.2 Orthobiologics Procedures, China, 2012-2020
9 Orthopedic Prosthetics, China
9.1 Amputation Procedures, China, 2005-2012
9.2 Amputation Procedures, China, 2012-2020
10 Shoulder Replacement Procedures, China
10.1 Shoulder Replacement Procedures, China, 2005-2012
10.2 Shoulder Replacement Procedures, China, 2012-2020
China Pharmaceutical Distribution Industry Report, 2013
Thanks to the continuous advancement in new medical reform, China’s pharmaceutical distribution industry has maintained a fairly rapid growth in recent years, with the sales value showed a CAGR of roughly 20% in 2005-2013. As the leading players in China’s pharmaceutical distribution industry, Shanghai Pharma, Jointown and China National Accord Medicines achieved the revenue of RMB58.1 billion, RMB24.8 billion, RMB15.8 billion, respectively, in the first three quarters of 2013.
In terms of drug categories, western medicine constitutes the first major category in Chinese medicine distribution market, accounting for approximately 70% of total revenue from Chinese pharmaceutical products during 2012-2013. Then what comes the next are Chinese patent medicine and traditional Chinese medicinal materials, which occupied 16.8% and 4.5%, respectively, of total revenue. In terms of distribution channels, the proportion of China's drug retail terminal and hospital terminal market share stood at 1:4.
The concentration of Chinese pharmaceutical distribution industry is relatively low. Take pharmaceutical chain market for example. In recent years, China's top 100 pharmaceutical chain enterprises have seen a rise in market share, but still less than 40%. In 2013, China's top 100 pharmaceutical chain enterprises posted a total of RMB98.36 billion in sales, up 11.9% from a year earlier. Guoda Drugstore under China National Accord Medicines still firmly held the first place in China's top 100 pharmaceutical chain enterprises, with the sales value for 2013 hitting RMB5.7 billion, a roughly 20% increase.
To download full report with TOC: http://www.marketresearchreports.biz/sample/sample/195379.
Table of Contents
1. Overview of Pharmaceutical Distribution Industry
1.2 Industry Chain
1.3 Strength and Weakness of Pharmaceutical Chain Enterprises
1.3.1 Strength of Pharmaceutical Chain Enterprises
1.3.2 Weakness of Pharmaceutical Chain Enterprises
2. Development of China Pharmaceutical Distribution Industry
2.1 Pharmaceutical Distribution Industry
2.2 Industry Environment
2.2.1 China’s Healthcare Spending
2.2.2 China\'s Healthcare Organizations
2.2.3 Contribution of Pharmaceutical Distribution Industry to GDP, Taxation and Employment
2.3 Relevant Policies
2.4 Market Size
3. China’s Top 100 Pharmacy Chains
3.1 Sales Scale
3.2 Store Analysis
3.2.1 Store Size
3.2.2 Sales per Unit Area
3.2.3 Pharmacies with Insurance Coverage
3.3 Consumer Analysis
3.3.2 Per Customer Transaction
3.3.3 Per Product Transaction
3.3.4 Average Sales Price
Global And China Display Driver & Touch IC Industry Report, 2013-2014
Global and China Display Driver & Touch IC Industry Report, 2013-2014 involves the following:
Introduction to Display Driver IC and Touch IC
Technology Trends of Small-, Medium- and Large-sized Touch screens
Status Quo and Trend of Metal Mesh and AgNW
Analysis on Display Downstream Market
Analysis on Display Driver IC Market and Industry
Analysis on Touch IC Market and Industry
11 Driver IC Design Houses
10 Touch IC Design Houses
In 2013, global display driver IC market size skyrocketed by 10.7% to USD 6.882 billion, and is expected to be worth USD 7.278 billion in 2014, with an increase of 5.6%. The rise in the display driver IC market scale can be attributed to the factors below:
To download full report with TOC: http://www.marketresearchreports.biz/sample/sample/193870.
Market acceptance of 4K2K UHD-TV exceeded expectations and it is expected that market size will expand rapidly.
Resolution of screens on mobile phones and tablet PCs improved significantly, and there will be at least 30 million mobile phones with QHD (Quad High Definition, 2560*1440) screens to be shipped in 2014, including blockbuster Samsung S5, G3 from LG, Lumia 1820 from Nokia, and Find7 from OPPO.
Resolution of computer display and notebook computer screen also improved substantially, and the number of Driver IC increased greatly.
The most noteworthy in Driver IC industry in 2014 is the sale of Display Driver IC unit by Renesas. Since its inception, Renesas has operated in the red. In order to dig its way out of losses, the company sold some non-core assets, while its medium and small-sized Display Driver IC unit is fairly profitable. Renesas is a principal supplier of driver IC for Apple phones, but its main business comes to MCU. Broadcom, Synaptics and Novatek will be the most likely buyers. Especially, Synaptics, a leading company in touch IC market, would become a dual leader in medium and small-sized Display Driver IC and Touch IC markets, if its bid for Renesas succeeded.
Marketresearchreports.biz is the most comprehensive collection of market research reports. Marketresearchreports.biz services are especially designed to save time and money of our clients. We are a one stop solution for all your research needs, our main offerings are syndicated research reports, custom research, subscription access and consulting services. We serve all sizes and types of companies spanning across various industries.
Office: United States
90 State Street, Suite 700
Albany, NY 12207
For the original version on PRWeb visit: http://www.prweb.com/releases/2014/04/prweb11769148.htm